Bio-Medical Applications Of Georgia, Inc. in Austell, Georgia - Dialysis Center

Bio-Medical Applications Of Georgia, Inc. is a medicare approved dialysis facility center in Austell, Georgia and it has 17 dialysis stations. It is located in Cobb county at 3602 Marathon Circle, Austell, GA, 30106. You can reach out to the office of Bio-Medical Applications Of Georgia, Inc. at (770) 222-0253. This dialysis clinic is managed and/or owned by Fresenius Medical Care. Bio-Medical Applications Of Georgia, Inc. has the following ownership type - Profit. It was first certified by medicare in April, 2016. The medicare id for this facility is 852507 and it accepts patients under medicare ESRD program.

Name	Bio-Medical Applications Of Georgia, Inc.
Location	3602 Marathon Circle, Austell, Georgia
No. of Dialysis Stations	17
Medicare ID	852507
Managed By	Fresenius Medical Care
Ownership Type	Profit
Late Shifts	No

Dialysis Facilities may have multiple NPI numbers. We have found possible NPI number/s associated with Bio-Medical Applications Of Georgia, Inc. from NPPES records by matching pattern on the basis of name, address, phone number etc. Please use this information accordingly.

NPI Number	1053780338
Organization Name	Fresenius Medical Care Of Powder Springs
Doing Business As	Bio-medical Applications Of Georgia, Inc.
Address	3602 Marathon Cir Austell, Georgia, 30106
Phone Number	(770) 222-0253

Dialysis patients with Hemoglobin data

32

Adult patinets who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be atleast 1.7, that means they are receiving right amount of dialysis. Pediatric patients who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be 1.8.
Higher percentages should be better.

• Hemodialysis

  Adult patients getting regular hemodialysis at the center	72
  Adult patient months included in Kt/V greater than or equal to 1.2	601
  Percentage of adult patients getting regular hemodialysis at the center
  Percentage of pediatric patients getting regular hemodialysis at the center

An important goal of dialysis is to maintain normal levels of various minerals in the body, such as calcium. This shows the percentage of patients treated at Bio-Medical Applications Of Georgia, Inc. with elevated calcium levels.

Patients with hypercalcemia	74
Hypercalcemia patient months	611
Hypercalcemia patients with serumcalcium greater than 10.2 mg
Patients with Serumphosphor	79
Patients with Serumphosphor less than 3.5 mg/dL
Patients with Serumphosphor from 3.5 to 4.5 mg/dL
Patients with Serumphosphor from 4.6 to 5.5 mg/dL
Patients with Serumphosphor from 5.6 to 7 mg/dL
Patients with Serumphosphor greater than 7 mg/dL

The arteriovenous (AV) fistulae is considered long term vascular access for hemodialysis because it allows good blood flow, lasts a long time, and is less likely to get infected or cause blood clots than other types of access. Patients who don't have time to get a permanent vascular access before they start hemodialysis treatments may need to use a venous catheter as a temporary access.

Patients included in arterial venous fistula and catheter summaries	84
Patient months included in arterial venous fistula and catheter summaries	490
Percentage of patients getting regular hemodialysis at the center that used an arteriovenous (AV) fistulae for their treatment
Percentage of patients receiving treatment through Vascular Catheter for 90 days/longer

The rate of hospitalization show you whether patients who were being treated regularly at a certain dialysis center were admitted to the hospital more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other centers.

Standard Hospitalization Summary Ratio(SHR) Year	January, 2016 - December, 2016
Patients in facility's Hospitalization Summary
Hospitalization Rate in facility	(Not Available)
Hospitalization Rate: Upper Confidence Limit
Hospitalization Rate: Lower Confidence Limit